NEW YORK — The U.S. Federal Trade Commission on Tuesday kicked off the trial of its civil case against Vyera Pharmaceuticals founder Martin Shkreli, grilling company executives about a deal with a Japanese supplier that the FTC said helped Vyera maintain its monopoly on the life-saving drug Daraprim. Read More

Daily Digest Signup

Daily business and market business news, business management tips, market research insights, and more.


Smart public opinion research for everyone.

Generated by Feedzy
%d bloggers like this: